Orange Book product · Brand (NDA)
PBZ-SR
TRIPELENNAMINE HYDROCHLORIDE
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
TRIPELENNAMINE HYDROCHLORIDE
Strength
50MG
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
TE code
Not listed
Application
NDA 010533
Product number
002
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- —PBZBrand (NDA)
NDA 005914 · NOVARTIS
- —PBZGeneric (ANDA)
ANDA 083149 · NOVARTIS
- —TRIPELENNAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 083037 · ANABOLIC
- —TRIPELENNAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 080744 · BARR
- —TRIPELENNAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 083989 · HEATHER
- —TRIPELENNAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 080785 · IMPAX LABS
- —TRIPELENNAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 083557 · LANNETT
- —TRIPELENNAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 085412 · NYLOS
- —TRIPELENNAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 083625 · PARKE DAVIS
- —TRIPELENNAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 083626 · PARKE DAVIS
- —TRIPELENNAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 080713 · WATSON LABS
- —TRIPELENNAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 080790 · WATSON LABS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
